Breaking News Instant updates and real-time market news.

RARE

Ultragenyx

$53.12

-0.81 (-1.50%)

21:09
11/05/18
11/05
21:09
11/05/18
21:09

Ultragenyx to see a number of near-term catalysts, says Piper Jaffray

Piper Jaffray analyst Christopher Raymond kept his Overweight rating and $70 price target on Ultragenyx after its Q3 update marked the first full quarter of sales of Crysvita. The analyst notes that the launch has continued its momentum with other positive also coming from Mepsevii and its approval in all 28 E.U. countries and Brazil. Raymond further states that a number of near-term catalysts remain for Ultragenyx in 2018, such as the initial update on DTX401 in Glycogen storage disease, keeping a constructive view on the stock.

  • 05

    Nov

  • 12

    Nov

  • 27

    Nov

RARE Ultragenyx
$53.12

-0.81 (-1.50%)

10/29/18
MSCO
10/29/18
NO CHANGE
Target $70
MSCO
Equal Weight
Ultragenyx price target lowered to $70 from $92 at Morgan Stanley
After Ultragenyx announced the discontinuation of UX007 in glucose transporter-type-1 deficiency syndrome, or Glut1 DS, following a negative Phase 3 result, Morgan Stanley analyst Jeffrey Hung removed this indication from his model, which lowered his price target on the stock to $70 from $92. He keeps an Equal Weight rating on Ultragenyx shares, citing his belief that expectations of a strong Crysvita launch are largely priced in and that the company's pipeline, while diverse, is made up of therapies still a number of years from market.
10/29/18
RHCO
10/29/18
NO CHANGE
Target $54
RHCO
Buy
Ultragenyx price target lowered to $54 from $83 at SunTrust
SunTrust analyst Edward Nash lowered his price target on Ultragenyx to $54 after the company's announcement that its Phase 3 study of UX007 did not meet a primary endpoint objective. The analyst also keeps his Buy rating, stating that the discontinuation should not have a large impact on the company's C-FAOD program, with near-term catalysts for Ultragenyx coming from "data from the first dose cohort of a Phase I/II study from DTX401 for GSD" and from the "FDA agreement to accept the NDA application of UX007 for LC-FAOD".
10/26/18
PIPR
10/26/18
NO CHANGE
Target $70
PIPR
Overweight
Ultragenyx price target lowered to $70 from $89 at Piper Jaffray
Piper Jaffray analyst Christopher Raymond lowered his price target for Ultragenyx Pharmaceutical to $70 following this morning's announcement that UX007 missed primary and key secondary endpoints in its Phase 3 study in patients with glucose transporter type-1 deficiency syndrome. The analyst removed Glut1 DS revenue from his model entirely with Ultragenyx discontinuing the program. Raymond, however, keeps an Overweight rating on the shares. He points out that early filing plans for UX007 in long-chain fatty oxidation disorders are on track. Ultragenyx in morning trading is down 15%, or $9.15, to $50.21.
09/27/18
PIPR
09/27/18
NO CHANGE
PIPR
Overweight
Ultragenyx given little credit for gene therapy efforts, says Piper Jaffray
Piper Jaffray analyst Christopher Raymond finds it "somewhat puzzling" that investors appear to be giving Ultragenyx little credit for its gene therapy efforts despite the early clinical signals of efficacy seen from DTX301 after data from two cohorts of its ongoing Phase 1/2 study. He thinks this may start to change with more readouts for DTX401 in the second half of 2018 and for DTX301 in mid-2019. On DTX301 gene therapy for ornithine transcarbamylase deficiency, Raymond thinks it "is a dosing matter" and awaits to see if a higher dose can in fact elicit more responses. He maintains an Overweight rating on Ultragenyx shares.

TODAY'S FREE FLY STORIES

HOG

Harley-Davidson

$40.65

3.515 (9.47%)

15:02
10/22/19
10/22
15:02
10/22/19
15:02
Recommendations
Harley-Davidson analyst commentary  »

Harley-Davidson estimates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

TTD

Trade Desk

$189.94

-10.99 (-5.47%)

, ROKU

Roku

$127.31

-5.63 (-4.24%)

15:02
10/22/19
10/22
15:02
10/22/19
15:02
Recommendations
Trade Desk, Roku analyst commentary  »

SunTrust reiterates a Buy…

TTD

Trade Desk

$189.94

-10.99 (-5.47%)

ROKU

Roku

$127.31

-5.63 (-4.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 07

    Nov

  • 19

    Nov

  • 21

    Nov

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$300.08

0.03 (0.01%)

14:58
10/22/19
10/22
14:58
10/22/19
14:58
General news
U.K. government not ruling out seeking short Brexit delay, Bloomberg says »

Bloomberg cites comments…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$300.08

0.03 (0.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNAP

Snap

$14.04

-0.54 (-3.70%)

, FB

Facebook

$183.72

-6.1 (-3.21%)

14:57
10/22/19
10/22
14:57
10/22/19
14:57
On The Fly
Fly Intel: What to watch in Snap earnings report »

Snap Inc. (SNAP) is…

SNAP

Snap

$14.04

-0.54 (-3.70%)

FB

Facebook

$183.72

-6.1 (-3.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 22

    Oct

  • 23

    Oct

  • 27

    Oct

  • 30

    Oct

  • 21

    Nov

SERV

ServiceMaster

$45.81

-10.26 (-18.30%)

14:54
10/22/19
10/22
14:54
10/22/19
14:54
Recommendations
ServiceMaster analyst commentary  »

ServiceMaster weakness an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

  • 12

    Nov

  • 13

    Nov

  • 14

    Nov

  • 15

    Nov

  • 19

    Nov

WFC

Wells Fargo

$50.82

0.37 (0.73%)

14:54
10/22/19
10/22
14:54
10/22/19
14:54
Downgrade
Wells Fargo rating change  »

Wells Fargo downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

  • 29

    Oct

  • 12

    Nov

  • 14

    Jan

SNAP

Snap

$14.08

-0.5 (-3.43%)

14:49
10/22/19
10/22
14:49
10/22/19
14:49
Options
Snap Inc. options imply 26.3% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 21

    Nov

GILD

Gilead

$66.32

1.11 (1.70%)

14:45
10/22/19
10/22
14:45
10/22/19
14:45
Options
Gilead call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 06

    Nov

  • 07

    Dec

SPY

SPDR S&P 500 ETF Trust

$300.58

0.53 (0.18%)

, SPX

S&P 500

$0.00

(0.00%)

14:41
10/22/19
10/22
14:41
10/22/19
14:41
General news
U.K. Parliament rejects timetable bill for exit from EU »

U.K. lawmakers rejected a…

SPY

SPDR S&P 500 ETF Trust

$300.58

0.53 (0.18%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$340.23

9.11 (2.75%)

14:34
10/22/19
10/22
14:34
10/22/19
14:34
On The Fly
Fly Intel: What to watch in Boeing's earnings report »

Boeing (BA) is scheduled…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

FB

Facebook

$183.45

-6.37 (-3.36%)

, GOOG

Alphabet

$1,246.51

0.28 (0.02%)

14:25
10/22/19
10/22
14:25
10/22/19
14:25
Periodicals
U.S antitrust chief says breakup of 'Big Tech' is 'on the table,' WSJ reports »

Makan Delrahim, the U.S.…

FB

Facebook

$183.45

-6.37 (-3.36%)

GOOG

Alphabet

$1,246.51

0.28 (0.02%)

AMZN

Amazon.com

$1,769.36

-15.37 (-0.86%)

AAPL

Apple

$242.10

1.61 (0.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 23

    Oct

  • 24

    Oct

  • 27

    Oct

  • 28

    Oct

  • 29

    Oct

  • 30

    Oct

  • 30

    Oct

  • 21

    Nov

GME

GameStop

$6.30

0.37 (6.24%)

14:25
10/22/19
10/22
14:25
10/22/19
14:25
Options
GameStop call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

SPY

SPDR S&P 500 ETF Trust

$300.50

0.45 (0.15%)

, SPX

S&P 500

$0.00

(0.00%)

14:17
10/22/19
10/22
14:17
10/22/19
14:17
General news
Brexit withdrawal agreement bill passes by 329-299 vote, Bloomberg reports »

The U.K. Parliament is…

SPY

SPDR S&P 500 ETF Trust

$300.50

0.45 (0.15%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
10/22/19
10/22
14:17
10/22/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
10/22/19
10/22
14:16
10/22/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:10
10/22/19
10/22
14:10
10/22/19
14:10
Conference/Events
Senate Commerce, Science & Transportation Committee to hold a hearing »

The Subcommittee on…

UTX

United Technologies

$141.32

3.08 (2.23%)

, BA

Boeing

$339.38

8.26 (2.49%)

14:09
10/22/19
10/22
14:09
10/22/19
14:09
Periodicals
United Tech sees no extra cut in Boeing 737 MAX production in 2019, Reuters says »

United Technologies (UTX)…

UTX

United Technologies

$141.32

3.08 (2.23%)

BA

Boeing

$339.38

8.26 (2.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 23

    Oct

LLY

Eli Lilly

$109.84

1.9 (1.76%)

14:09
10/22/19
10/22
14:09
10/22/19
14:09
Earnings
Fly Intel: What to watch in Eli Lilly earnings report »

Eli Lilly (LLY) is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 28

    Oct

FCX

Freeport McMoRan

$9.95

0.13 (1.32%)

14:05
10/22/19
10/22
14:05
10/22/19
14:05
Options
Freeport McMoRan call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

WBS

Webster Financial

$44.80

-2.51 (-5.31%)

14:01
10/22/19
10/22
14:01
10/22/19
14:01
Downgrade
Webster Financial rating change  »

Compass Point cuts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 13

    Nov

WBS

Webster Financial

$44.69

-2.62 (-5.54%)

13:58
10/22/19
10/22
13:58
10/22/19
13:58
Downgrade
Webster Financial rating change  »

Webster Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 13

    Nov

13:55
10/22/19
10/22
13:55
10/22/19
13:55
Conference/Events
House Financial Services Committee to hold a hearing »

The Subcommittee on…

SYMC

Symantec

$23.19

0.11 (0.48%)

13:55
10/22/19
10/22
13:55
10/22/19
13:55
Conference/Events
House Committee on Homeland Security to hold a hearing »

The Cybersecurity,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

LYFT

Lyft

$44.73

3.87 (9.47%)

, UBER

Uber

$33.79

2.375 (7.56%)

13:47
10/22/19
10/22
13:47
10/22/19
13:47
Recommendations
Lyft, Uber analyst commentary  »

Lyft profit call…

LYFT

Lyft

$44.73

3.87 (9.47%)

UBER

Uber

$33.79

2.375 (7.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 04

    Nov

  • 07

    Nov

  • 19

    Nov

  • 21

    Nov

  • 04

    Dec

FEYE

FireEye

$15.67

0.255 (1.65%)

13:45
10/22/19
10/22
13:45
10/22/19
13:45
Options
FireEye call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 09

    Dec

  • 12

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.